RVL Pharmaceuticals plc Depreciation
RVL Pharmaceuticals plc reported Depreciation of $400.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-20.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2023-03-20
- RVL Pharmaceuticals plc depreciation for fiscal 2022 was $400.00K, a 73.33% decline from fiscal 2021.
- RVL Pharmaceuticals plc depreciation for fiscal 2021 was $1.50M, a 21.05% decline from fiscal 2020.
- RVL Pharmaceuticals plc depreciation for fiscal 2020 was $1.90M.
- RVL Pharmaceuticals plc depreciation for fiscal 2018 was $4.50M.
| Period end | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|
| 2022-12-31 | $400.00K 10-K · filed 2023-03-20 | |
| 2021-12-31 | $1.50M 10-K · filed 2023-03-20 | |
| 2020-12-31 | $1.90M 10-K · filed 2022-03-30 | $5.00M 10-K · filed 2021-03-30 |
| 2019-12-31 | $1.30M 8-K · filed 2021-09-08 | $4.40M 10-K · filed 2020-03-19 |
| 2018-12-31 | $4.50M 10-K · filed 2020-03-19 | $4.48M 10-K · filed 2019-03-28 |
| 2017-12-31 | $3.07M 8-K · filed 2019-12-20 |